| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |